This test uses qualitative Polymerase Chain Reaction (PCR) technology to detect the presence of Human Immunodeficiency Virus type 1 (HIV-1) and/or type 2 (HIV-2) RNA in a plasma blood sample. It is characterized by its ability to detect infection within 10-15 days after exposure, i.e., before the appearance of antibodies detectable by traditional serological tests.